Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...
Passed away peacefully on Thursday 23rd January 2025, aged 91 years. Funeral service will be held on Monday 17th February at ...
1d
Boxer Mark Weinman, who returned from a nearly 21-year layoff to win a professional bout at age 50, has died. Weinman, from the borough of Queens in New York City, died Feb. 8 in Mesa, Arizona, his ...
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Columnist Sam Kirton has spent years finding calm through a popular British phrase, which has allowed him to carry on through medical crises.
The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Topline data from FIBRONEER-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 vers ...
A heartfelt tribute to a much-loved dad and grandad from Exeter following his death last month. The family of Patrick 'Paddy' ...
Patrick Shawn O'Hea Patrick Shawn O'Hea, beloved husband of 42 years, father, "papa," brother, uncle, and dear friend, passed away on the 13th of January, 2025 after a long struggle with diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback